These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6682841)

  • 1. Genetic influence on natural cytotoxicity and interferon production in multiple sclerosis studies in monozygotic discordant twins.
    Kaudewitz P; Zander H; Abb J; Ziegler-Heitbrock HW; Riethmüller G
    Hum Immunol; 1983 May; 7(1):51-8. PubMed ID: 6682841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis.
    Gyódi E; Benczur M; Pálffy G; Tálas M; Petrányi G; Földes I; Hollán SR
    Hum Immunol; 1982 Jun; 4(3):209-17. PubMed ID: 6181031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between impaired interferon production and natural killer activity of lymphocytes in multiple sclerosis.
    Stöger I; Tálas M; Benczúr M; Gyódi E; Petrányi GG; Pálffy G; Kotsy B
    Arch Virol; 1982; 71(3):259-65. PubMed ID: 6179500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.
    Neighbour PA; Grayzel AI; Miller AE
    Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparate responses of lymphocyte clones to cells of monozygotic twins discordant for multiple sclerosis.
    Birnbaum G; Kotilinek L; Schwartz M; Sternad M
    J Neuroimmunol; 1986 May; 11(3):237-43. PubMed ID: 3485657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of some immunological variables in twins, discordant for multiple sclerosis.
    Heltberg A; Kalland T; Källén B; Nilsson O
    Eur Neurol; 1985; 24(6):361-73. PubMed ID: 2933257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killing activity and interferon production in multiple sclerosis.
    Zander H; Abb J; Kaudewitz P; Riethmüller G
    Lancet; 1982 Jan; 1(8266):280. PubMed ID: 6173558
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2.
    Hirsch RL; Johnson KP
    Clin Immunol Immunopathol; 1985 Nov; 37(2):236-44. PubMed ID: 3899434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of adherent cells in supporting natural cytotoxicity reactions].
    Sorokin AM; Chenëv SB; Koval'chuk LV
    Biull Eksp Biol Med; 1989 Sep; 108(9):322-5. PubMed ID: 2611391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients.
    Neighbour PA
    Ann N Y Acad Sci; 1984; 436():181-91. PubMed ID: 6085226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis in twins.
    Williams A; Eldridge R; McFarland H; Houff S; Krebs H; McFarlin D
    Neurology; 1980 Nov; 30(11):1139-47. PubMed ID: 7191511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
    Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
    Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
    Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires.
    Haegert DG; Galutira D; Murray TJ; O'Connor P; Gadag V
    Clin Exp Immunol; 2003 Dec; 134(3):532-7. PubMed ID: 14632762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.
    Braakman E; van Tunen A; Meager A; Lucas CJ
    Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible risk factors in multiple sclerosis as found in a national twin study.
    Currier RD; Eldridge R
    Arch Neurol; 1982 Mar; 39(3):140-4. PubMed ID: 7199899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis.
    Utz U; Biddison WE; McFarland HF; McFarlin DE; Flerlage M; Martin R
    Nature; 1993 Jul; 364(6434):243-7. PubMed ID: 7686632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis.
    Uchida A; Maida EM; Lenzhofer R; Micksche M
    Immunobiology; 1982 Feb; 160(5):392-402. PubMed ID: 6175561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.